Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Henrik Boye, Jensen"'
Autor:
Jon Skovgaard Jensen, Anders Stengaard Sørensen, Christina Kruuse, Helle Hvilsted Nielsen, Cecilie Dollerup Skov, Henrik Boye Jensen, Marion S. Buckwalter, Jens Bojsen-Møller, Kate Lykke Lambertsen, Anders Holsgaard-Larsen
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Body weight unloaded treadmill training has shown limited efficacy in further improving functional capacity after subacute rehabilitation of ischemic stroke patients. Dynamic robot assisted bodyweight unloading is a novel technolo
Externí odkaz:
https://doaj.org/article/2eac36aab2944f43b61152d1ed9ea613
Autor:
Sepehr Mamoei, Henrik Boye Jensen, Andreas Kristian Pedersen, Mikkel Karl Emil Nygaard, Simon Fristed Eskildsen, Ulrik Dalgas, Egon Stenager
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: Persons with multiple sclerosis (PwMS), already established as responders or non-responders to Fampridine treatment, were compared in terms of disability measures, physical and cognitive performance tests, neurophysiology, and magnetic res
Externí odkaz:
https://doaj.org/article/90a3582143a64ba8837cb90cfd1f6cf2
Autor:
Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, Mikkel Karl Emil Nygaard, Simon Fristed Eskildsen, Tobias Gaemelke, Melinda Magyari, Henrik Boye Jensen, Helle Hvilsted Nielsen, Matthias Kant, Masoud Falah, Thor Petersen, Egon Stenager, Ulrik Dalgas
Publikováno v:
Riemenschneider, M, Hvid, L G, Ringgaard, S, Nygaard, M K E, Eskildsen, S F, Gaemelke, T, Magyari, M, Jensen, H B, Nielsen, H H, Kant, M, Falah, M, Petersen, T, Stenager, E & Dalgas, U 2022, ' Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis : The Early Multiple Sclerosis Exercise Study (EMSES) ', Multiple sclerosis (Houndmills, Basingstoke, England), vol. 28, no. 10, pp. 1620-1629 . https://doi.org/10.1177/13524585221079200
Background: Potential supplemental disease-modifying and neuroprotective treatment strategies are warranted in multiple sclerosis (MS). Exercise is a promising non-pharmacological approach, and an uninvestigated ‘window of opportunity’ exists ear
Autor:
Maria Thorning, Kate Lykke Lambertsen, Cecilie Dollerup Skov, Lars Henrik Frich, Henrik Boye Jensen, Anders Holsgaard-Larsen, Helle Hvilsted Nielsen
Publikováno v:
Multiple sclerosis and related disorders. 70
Despite the wide range of existing performance measures to evaluate functional status of patients with multiple sclerosis, the heterogeneous nature of the disease hinders clinical characterization and monitoring of disease severity. Speckle tracking
Autor:
Trine Andreasen Leth, Anita Nymark, Fredrikke Christie Knudtzen, Sanne Løkkegaard Larsen, Marianne N. Skov, Thøger Gorm Jensen, Malene Bek-Thomsen, Henrik Boye Jensen, Joppe W. Hovius, Sigurdur Skarphédinsson, Jens Kjølseth Møller, Nanna Skaarup Andersen
Publikováno v:
Ticks and tick-borne diseases, 14(3):102138. Elsevier GmbH
Molecular methods for diagnosing Lyme neuroborreliosis (LNB) have shown suboptimal diagnostic sensitivities. The objective of this study was to improve the clinical sensitivity of PCR detection of Borrelia burgdorferi sensu lato spirochetes by inocul
Autor:
Cecilie Dollerup Skov, Christina Borgen Sørensen, Maria Thorning, Kate Lykke Lambertsen, Lars Henrik Frich, Henrik Boye Jensen, Anders Holsgaard-Larsen, Helle H Nielsen
Publikováno v:
Multiple sclerosis and related disorders. 66
The purpose of this interventional study on participants with multiple sclerosis (MS) with walking disability was to evaluate changes in functional hand and walking measurements after fampridine treatment, after stratifying by the Expanded Disability
Publikováno v:
Mamoei, S, Hvid, L G, Boye Jensen, H, Zijdewind, I, Stenager, E & Dalgas, U 2020, ' Neurophysiological impairments in multiple sclerosis : central and peripheral motor pathways ', Acta Neurologica Scandinavica, vol. 142, no. 5, pp. 401-417 . https://doi.org/10.1111/ane.13289
Acta neurologica Scandinavica, 142(5), 401-417. Wiley
Mamoei, S, Hvid, L G, Boye Jensen, H, Zijdewind, I, Stenager, E & Dalgas, U 2020, ' Neurophysiological impairments in multiple sclerosis-Central and peripheral motor pathways ', Acta Neurologica Scandinavica. Supplementum, vol. 142, no. 5, pp. 401-417 . https://doi.org/10.1111/ane.13289
Acta neurologica Scandinavica, 142(5), 401-417. Wiley
Mamoei, S, Hvid, L G, Boye Jensen, H, Zijdewind, I, Stenager, E & Dalgas, U 2020, ' Neurophysiological impairments in multiple sclerosis-Central and peripheral motor pathways ', Acta Neurologica Scandinavica. Supplementum, vol. 142, no. 5, pp. 401-417 . https://doi.org/10.1111/ane.13289
A systematic review of the literature was conducted comparing neurophysiological outcomes in persons with multiple sclerosis (PwMS) to healthy controls (HC), in studies of the central nervous system (CNS) function comprising motor evoked potentials (
Autor:
Line, Lunau, Henrik Boye, Jensen
Publikováno v:
Ugeskrift for laeger. 183(41)
This is a review of the summarised evidence behind early supported discharge in stroke, and our experiences. We found a reasonable amount of randomised studies, measuring rehabilitation on different quantitative scales. None of these studies showed,
Autor:
Maria Thorning, Helle Hvilsted Nielsen, Lars Henrik Frich, Henrik Boye Jensen, Kate Lykke Lambertsen, Anders Holsgaard-Larsen
Publikováno v:
Clinical Biomechanics. 100:105826
Fampridine has shown to improve walking speed, motor control, and balance in patients with multiple sclerosis. However, potential fampridine-induced changes in gait quality and underlying mechanisms, evaluated by three-dimensional gait analysis, are
Autor:
Julie Ravn, Henrik Boye Jensen, Matthias Kant, Preben Borring Andersen, Monika Katarzyna Góra, Tobias Sejbaek
Publikováno v:
Multiple Sclerosis and Related Disorders. 67:104081
Dimethyl fumarate (DMF, Tecfidera®) is a first-line disease-modifying therapy for relapsing-remitting multiple sclerosis. Lymphopenia is a frequent reason for discontinuation in fumarate-treated patients. Management strategies to minimize risk of ly